Skip to main content
BeNeLuxA

Hauptnavigation

  • News
    • Steering Committee Meeting of the Beneluxa Initiative in Brussels, Belgium
    • Statement of the Beneluxa Initiative on a more unified European approach to access to and affordability of pharmaceutical products
    • The Beneluxa Initiative identified impactful medicines suitable for joint HTA submission
    • Archive
  • About
    • Beneluxa initiative
    • Mandate and organisation
    • Benefits
  • Statements
  • Activities
    • Horizon Scanning
    • Health Technology Assessment
      • HTA procedures within the Beneluxa Initiative
    • Information Sharing
      • Patient registries
    • Pricing and reimbursement
  • Documents
    • Background documents
    • Publications
    • Press releases
    • Templates
  • Contact
  • xclose

Zweite Menüebene Hauptnavigation

  • Steering Committee Meeting of the Beneluxa Initiative in Brussels, Belgium
  • Statement of the Beneluxa Initiative on a more unified European approach to access to and affordability of pharmaceutical products
  • The Beneluxa Initiative identified impactful medicines suitable for joint HTA submission
  • Archive
  • xclose

News

Contact

info@beneluxa.org

Info

Legal disclosure

Privacy policy

Links

About

Back to top